Evidence map›Paper›PMID 22262463›Full record

ArticleMolecular biology of the cell2012

The first luminal loop confers insulin responsiveness to glucose transporter 4.

Ju Youn Kim, Konstantin V Kandror

Abstract read
In one paragraph

Article in Molecular biology of the cell, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Detection of Detergent-sensitive Interactions Between Membrane Proteins.Journal of visualized experiments : JoVE · 2018
    Article
  5. Article
  6. Internalization of the Active Subunit of theFrontiers in cellular and infection microbiology · 2017
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ju Youn KimDepartment of Biochemistry, Boston University School of Medicine, Boston, MA 02118, USA.
Konstantin V Kandror

Funding

INSULIN REGULATION OF CELL NUTRITIONR01DK052057 · NIDDK · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KANDROR, KONSTANTIN V · 1997 to 2023
$7.1M
SECRETION FROM ADIPOSE CELLSR01DK056736 · NIDDK · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KANDROR, KONSTANTIN V · 2000 to 2010
$2.5M
Insulin regulation of cell nutritionR56DK052057 · NIDDK · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KANDROR, KONSTANTIN V · 2008 to 2014
$418k
NIDDK NIH HHS DK52057NIDDK NIH HHS DK56736NIDDK NIH HHS R01 DK052057NIDDK NIH HHS R01 DK056736NIDDK NIH HHS R56 DK052057
6 · The paper itself

Abstract

Glucose transporter isoform 4 (GLUT4), is the sole glucose transporter responsible for the effect of insulin on postprandial blood glucose clearance. However, the nature of the insulin sensitivity of GLUT4 remains unknown. In this study, we replaced the first luminal loop of cellugyrin, a 4-transmembrane protein that does not respond to insulin, with that of GLUT4. The chimera protein is targeted to the intracellular insulin-responsive vesicles and is translocated to the plasma membrane upon insulin stimulation. The faithful targeting of the chimera depends on the expression of the sorting receptor sortilin, which interacts with the unique amino acid residues in the first luminal loop of GLUT4. Thus the first luminal loop may confer insulin responsiveness to the GLUT4 molecule.

Indexed as

Insulin Resistance3T3-L1 CellsAdaptor Proteins, Vesicular TransportAnimalsBlood GlucoseGlucose Transporter Type 4InsulinMembrane ProteinsMiceMutant Chimeric ProteinsNerve Tissue ProteinsSortilinSynaptogyrinsAdaptor Proteins, Vesicular TransportBlood GlucoseGlucose Transporter Type 4InsulinMembrane ProteinsMutant Chimeric ProteinsNerve Tissue ProteinsSortilinSynaptogyrins

Identifiers

PMID22262463
PMCPMC3290648

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.